Uncategorized

Syncell, a biotech company pioneering in platforms for hypothesis-free spatial proteomics, will be exhibiting and presenting a poster at the AACR Annual Meeting 2023 in Orlando, FL. Syncell’s Microscoop technology enables microscopy-guided subcellular protein scooping in ultra-content powered by AI to collect enough proteins for subsequent spatial proteomic identification.

2HCmed Innovations Co., Ltd., a contract development and manufacturing organization, announced the appointment of Gunilla Petersson, Ph.D. as the new Chief Scientific Officer.

Sobi® announced a streamlining and simplification of the contractual economics for nirsevimab.

A groundbreaking study by a team of scientists at YDS Pharmatech, Inc. has introduced an innovative Generative Diffusion Model for sampling ensembles of degrader-induced ternary interactions, enabling a more effective approach to structure-based optimization of Proteolysis Targeting Chimeras.

The FDA is set to decide on a Humira biosimilar and hold an Adcomm meeting for an Alzheimer’s agitation treatment. Also on its calendar for April are decision dates for two vaccine hopefuls.

Atiende en la región de El Soberbio Misiones, en cuatro centros de atención primaria y en diez aldeas de la comunidad mbya. Se instaló para “volver a los orígenes” e intercambiar saberes.

El manejo de esta entidad varía según el mecanismo subyacente por lo que se recomiendan enfoques sistémicos para el diagnóstico

El linfoma de Burkitt es un linfoma de células B muy agresivo y el cáncer humano de proliferación más rápida.

En todos los niveles de hernia de disco, la indicación quirúrgica absoluta incluye déficits neurológicos progresivos o síndrome de cauda equina. Sin embargo, existen indicaciones relativas a nivel cervical, torácico y lumbar.

The maker of subscription apps for insomnia and substance abuse began exploring strategic alternatives earlier this month, and is still seeking a sale.